These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26263978)

  • 21. Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites.
    Sun D; Rösler C; Kidd-Ljunggren K; Nassal M
    J Hepatol; 2010 Jun; 52(6):817-26. PubMed ID: 20400195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of CRISPR/Cas9 Technology to HBV.
    Lin G; Zhang K; Li J
    Int J Mol Sci; 2015 Nov; 16(11):26077-86. PubMed ID: 26540039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.
    Zhang X; Lu W; Zheng Y; Wang W; Bai L; Chen L; Feng Y; Zhang Z; Yuan Z
    J Clin Invest; 2016 Mar; 126(3):1079-92. PubMed ID: 26901811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the detection of HBV cccDNA and its clinical significance: an overview of research advancement].
    Li H; Tang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):662-6. PubMed ID: 19634693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA.
    Ahmed M; Wang F; Levin A; Le C; Eltayebi Y; Houghton M; Tyrrell L; Barakat K
    Drug Discov Today; 2015 May; 20(5):548-61. PubMed ID: 25622780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
    Takkenberg RB; Zaaijer HL; Molenkamp R; Menting S; Terpstra V; Weegink CJ; Dijkgraaf MG; Jansen PL; Reesink HW; Beld MG
    J Med Virol; 2009 Jun; 81(6):988-95. PubMed ID: 19382261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative analysis of drug resistant mutations in the reverse transcriptase domain of hepatitis B virus covalently closed circular DNA and the viral relax circle DNA].
    Su HL; Liu YM; Ren XQ; Xu DP; Zhong YW
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):818-21. PubMed ID: 21138628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus.
    Chen CC; Chang CM; Sun CP; Yu CP; Wu PY; Jeng KS; Hu CP; Chen PJ; Wu JC; Shih CH; Gershwin ME; Tao MH
    Gene Ther; 2012 Jan; 19(1):25-33. PubMed ID: 21562593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice.
    Li G; Jiang G; Lu J; Chen S; Cui L; Jiao J; Wang Y
    Cell Biochem Biophys; 2014 Jul; 69(3):649-54. PubMed ID: 24569930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Therapy for Chronic HBV-Can We Eliminate cccDNA?
    Bloom K; Maepa MB; Ely A; Arbuthnot P
    Genes (Basel); 2018 Apr; 9(4):. PubMed ID: 29649127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
    Takkenberg RB; Menting S; Beld MG
    Methods Mol Biol; 2012; 903():113-28. PubMed ID: 22782814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances with RNAi-Based Therapy for Hepatitis B Virus Infection.
    van den Berg F; Limani SW; Mnyandu N; Maepa MB; Ely A; Arbuthnot P
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32759756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in developing nucleic acid-based HBV therapy.
    Marimani M; Hean J; Bloom K; Ely A; Arbuthnot P
    Future Microbiol; 2013 Nov; 8(11):1489-504. PubMed ID: 24199806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early events in hepatitis B virus infection: From the cell surface to the nucleus.
    Hayes CN; Zhang Y; Makokha GN; Hasan MZ; Omokoko MD; Chayama K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):302-9. PubMed ID: 26414381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection.
    Allweiss L; Dandri M
    J Hepatol; 2016 Apr; 64(1 Suppl):S17-S31. PubMed ID: 27084033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy of hepadnavirus infection using antisense oligonucleotides.
    Offensperger WB; Blum HE; Gerok W
    Intervirology; 1995; 38(1-2):113-9. PubMed ID: 8666519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy.
    Bourne EJ; Dienstag JL; Lopez VA; Sander TJ; Longlet JM; Hall JG; Kwiatkowski RW; Wright T; Lai CL; Condreay LD
    J Viral Hepat; 2007 Jan; 14(1):55-63. PubMed ID: 17212645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.